Drug Shortage Report for TEVA-VARENICLINE
Report ID | 126955 |
Drug Identification Number | 02426781 |
Brand name | TEVA-VARENICLINE |
Common or Proper name | VARENICLINE COMBO 0.5/1MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VARENICLINE VARENICLINE |
Strength(s) | 0.5MG 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 25UD & 53UD |
ATC code | N07BA |
ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-10-21 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-07-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-07-15 | French | Compare |
v5 | 2021-07-15 | English | Compare |
v4 | 2021-02-05 | French | Compare |
v3 | 2021-02-05 | English | Compare |
v2 | 2020-10-22 | French | Compare |
v1 | 2020-10-22 | English | Compare |
Showing 1 to 6 of 6